Find Federal Grants
FY 2023 Phase I Release 2
Office of Science · DE-FOA-0002903
In Vivo Regional Deposition Measurements for Supporting Model Validation (U01) Clinical Trial Required
Food and Drug Administration · RFA-FD-23-014
Global Health Engagement Research Initiative (GHERI) FY 2023 Pre-Application (Call for White Papers)
Uniformed Services Univ. of the Health Sciences · HU000123CGHE0001
Defense Production Act Title III Expansion of Domestic Production Capability and Capacity; CALL 012 - Critical Chemicals Production
Air Force -- Research Lab · FA8650-19-S-5010-CALL-012
Defense Health Agency Contracting Activity - DHACA · HT9425-23-RTRP-CNA
Office of Science · DE-FOA-0002889
Bureau of European and Eurasian Affairs · TR-APS-FY23-01
Administration for Community Living · HHS-2023-ACL-NIDILRR-SFGE-0000
Office of Science · DE-FOA-0002884
NASA Headquarters · NNH22ZDA001N-SLIT
Climate Resilience Centers
Office of Science · DE-FOA-0002915
NOAA SBIR FY 2023 Phase I
Department of Commerce · NOAA-OAR-TPO-2023-2007691
NASA Johnson Space Center · NNJ23ZSA001N-OMNIBUS
NASA Johnson Space Center · NNJ23ZSA001N
NASA Headquarters · NNH22ZDA001N-HPOSS
Office of Science · DE-FOA-0002878
U.S. National Science Foundation · 23-525
Cooperative Agreement to Support Regulatory Research Related to the 2023 Prescription Drug User Fee Act
Food and Drug Administration · RFA-FD-23-023
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Food and Drug Administration · RFA-FD-23-012
Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed
Food and Drug Administration · RFA-FD-23-017